세계 일주기 리듬 수면장애 시장 규모는 2023년 7억 6,123만 달러에 달했습니다. 이 시장은 2024년부터 2030년까지 예측 기간 동안 연평균 6.88% 성장하여 2030년에는 12억 886만 달러에 달할 것으로 예상됩니다. 일주기 리듬 수면 장치 및 약물에 대한 수요는 주로 수면장애의 유병률 증가에 의해 주도되고 있습니다. 이 수면장애는 높은 스트레스 수준, 불규칙한 근무 일정, 과도한 스크린 시간, 알코올 및 카페인 섭취 증가 등 여러 요인의 영향을 받습니다. 또한, 노인 인구 증가와 양질의 수면의 이점을 강조하는 수면 교육 캠페인 증가도 2024-2030년의 예측 기간 동안 시장 성장에 기여하는 주요 요인 중 하나입니다.
미국 질병통제예방센터(Centers for Disease Control and Prevention 2023)가 제공한 데이터에 따르면, 2021년 미국 성인 인구 약 2,830만 명 중 약 11.5%가 담배를 피우는 것으로 추정됩니다. 담배에 함유된 니코틴은 수면 패턴을 방해하고 수면장애를 일으킬 가능성을 높입니다. 흡연 증가는 불면증과 일주기 수면장애와 같은 수면장애의 유병률을 증가시키는 경향이 있으며, 이는 일주기 수면장애 치료제 시장의 긍정적인 성장에 영향을 미칠 것으로 보입니다.
수면장애 증가의 또 다른 중요한 요인은 스크린 사용 시간 증가와 노동 시간의 연장입니다. 2023년 경제협력개발기구(OECD)에 따르면 미국의 1인당 연간 평균 노동 시간은 1,791시간에 달하고, 2021년 OECD 평균 1,716시간을 넘어설 것으로 예상됩니다. 일본 역시 OECD 평균인 10%에 비해 유급직 종사자 중 장시간 근무하는 비율이 높은 것으로 추정됩니다. 이러한 장시간 노동은 수면 부족을 초래하고 전반적인 삶의 질을 떨어뜨려 수면장애의 유병률 증가에 일조하고 있습니다. 따라서 예측 기간 동안 일주기 리듬 수면장애 치료 시장의 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.
이 보고서는 세계 일주기 리듬 수면장애 시장을 조사했으며, 시장 개요와 함께 제품 유형별/용도별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
Circadian Rhythm Sleep Disorders Market By Product Type (Device And Therapeutics), Application (Delayed Sleep-Wake Phase Disorder, Advanced Sleep-Wake Phase Disorder, Irregular Sleep Wake Rhythm, And Others), End-User (Hospitals, Sleep Clinics, Homecare, And Others) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of sleep disorders and increase in sleep awareness campaigns highlighting the advantages of high-quality sleep
The global circadian rhythm sleep disorders market was valued at USD 761.23 million in 2023, growing at a CAGR of 6.88% during the forecast period from 2024 to 2030 to reach USD 1,208.86 million by 2030. The demand for Circadian Rhythm Sleep devices and drugs is primarily being boosted by the rising prevalence of sleep disorders, which is influenced by many factors such as high stress levels, irregular work schedules, excessive screen time, and increasing consumption of alcohol and caffeine. Additionally, the rising geriatric population and increase in sleep awareness campaigns highlighting the advantages of high-quality sleep are some of the key factors that are contributing to the growth of the market during the forecast period from 2024-2030.
Circadian Rhythm Sleep Disorders Market Dynamics:
As per the data provided by the Centers for Disease Control and Prevention 2023, it was estimated that around 11.5% of people which accounted for around 28.3 million US adults were smoking cigarettes in the year 2021. Nicotine, found in tobacco, disrupts sleep patterns and increases the likelihood of developing sleep disorders. The rise in smoking will tend to increase the prevalence of sleep disorders such as insomnia and circadian rhythm sleep disorders, which will in return result in the positive growth of the Circadian Rhythm Sleep Disorders treatment market.
Another significant contributor to the rising sleep disorders is the escalation in screen time and extended working hours. According to the Organization for Economic Co-operation and Development (OECD) in 2023, the average annual hours worked per employee in the US reached 1,791, surpassing the 2021 OECD average of 1,716 hours per worker. Similarly, in Japan, a higher percentage of employees work excessively long hours in paid employment compared to the OECD average of 10%. These prolonged working hours contribute to sleep deprivation and diminish overall quality of life, thus contributing to the rising prevalence of sleep disorders. Therefore, positively influencing the growth of the Circadian Rhythm Sleep Disorders treatment market during the forecast period.
Additionally, an increase in sleep awareness campaigns highlighting the advantages of high-quality sleep by prominent organizations is another key factor accelerating the growth of the circadian rhythm sleep disorders treatment market. For instance, in September 2022, a National Campaign titled "Sleep is Good Medicine" was launched by the American Academy of Sleep Medicine to increase awareness regarding the importance of sleep and its connection to health. Further, in 2022, the Government of the UK launched the Rough Sleeping Initiative and made allocations for the first multi-year funding to provide local councils with long-term funding to support people who were sleeping rough or at risk of rough sleeping. Thus, the rising sleep awareness campaigns will tend to drive the growth of the overall circadian rhythm sleep disorders treatment market during the forecast period.
However, lack of awareness and diagnosis of sleep disorders and side effects associated with bright light therapy devices such as eye strain, headaches, nausea, or irritability, are some of the key constraints that may limit the growth of the Circadian Rhythm Sleep Disorders market.
Circadian Rhythm Sleep Disorders Market Segment Analysis:
Circadian Rhythm Sleep Disorders market by Product Type (Device and Therapeutics), Application (Delayed Sleep-Wake Phase Disorder, Advanced Sleep-Wake Phase Disorder, Irregular Sleep Wake Rhythm, and Others), End-User (Hospitals, Sleep clinics, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product segment of the circadian rhythm sleep disorders market, the devices category is estimated to amass a significant revenue share in the Circadian Rhythm Sleep Disorders market in 2023. This can be attributed to the various applications provided by these devices such as light therapy devices. Bright light therapy devices are used for the treatment of Circadian Rhythm Sleep Disorders, these devices help to regulate the body's internal clock, known as the circadian rhythm. Exposure to bright light, especially in the morning, can help synchronize the body's natural sleep-wake cycle with the external environment. Bright light therapy is non-invasive and generally well-tolerated by most individuals. Unlike medications or other more invasive treatments, it does not typically have significant side effects when used correctly. This makes it a safe and attractive treatment option for a wide range of people. Further, Bright light therapy can be administered at home or in clinical settings using portable light therapy devices. This offers convenience and flexibility for individuals who may not have access to specialized treatment centers or who prefer the convenience of home-based therapy.
Therefore, owing to the above-mentioned factors, the device category is expected to register significant growth, thereby driving the growth of the overall Circadian Rhythm Sleep Disorders treatment market during the forecast period.
North America Is Expected To Dominate The Overall Circadian Rhythm Sleep Disorders Market:
North America is expected to account for the highest proportion of the Circadian Rhythm Sleep Disorders Market in 2023, out of all regions. This can be attributed to the rising awareness regarding sleep disorders, increasing R&D activities, growing geriatric population, and increasing burden of sleep disorders in the region are some of the contributing factors to the growth of the circadian rhythm sleep disorder treatment market in North America.
According to data published by the Centers of Disease Control and Prevention 2022, it was estimated that approximately 14.5% of adults in the United States in the year 2020, had trouble falling asleep. Thus, the increasing burden of sleep disorders in the United States will eventually create a need for the management and treatment of such sleep disorders, which will further propel the market for the circadian rhythm sleep disorders treatment devices and rugs market in North America.
Further, key players present in the region, such as Pfizer, Northern Light Technologies and The Sunbox Company are currently driving a wide range of initiatives, such as enhancing market access and distribution, making investments in research and development and inking strategic collaborations and partnerships, which will further contribute for the growth of the Circadian Rhythm Sleep Disorders treatment market in North America.
Therefore, the factors mentioned above, are responsible for driving the overall market for circadian rhythm sleep disorders treatment market in North America during the forecast period.
Circadian Rhythm Sleep Disorders Market Key Players:
Some of the key market players operating in the Circadian Rhythm Sleep Disorders market include, Koninklijke Philips N.V., The Sunbox Company, Northern Light Technologies, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., VANDA PHARMACEUTICALS, Nature's Bounty, Verilux, Inc., OLLY Vitamins & Supplements, Pure Encapsulations, LLC, Vespyr Brands, NOW FOODS, Natrol, LLC., Pharmavite LLC, and Others.
Recent Developmental Activities In The Circadian Rhythm Sleep Disorders Market:
Key Takeaways From The Circadian Rhythm Sleep Disorders Market Report Study
Target Audience Who Can Be Benefited From This Circadian Rhythm Sleep Disorders Market Report Study
Circadian Rhythm Sleep Disorders product providers
Research organizations and consulting companies
Circadian Rhythm Sleep Disorders-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Circadian Rhythm Sleep Disorders
Various End-users who want to know more about the Circadian Rhythm Sleep Disorders Market and the latest technological developments in the Circadian Rhythm Sleep Disorders market.
Frequently Asked Questions For The Circadian Rhythm Sleep Disorders Market:
Circadian Rhythm Sleep Disorders are a group of conditions characterized by disruptions in the body's internal biological clock, known as the circadian rhythm, which regulates the sleep-wake cycle. These disorders result in difficulties falling asleep, staying asleep, or waking up at the desired times, leading to sleep disturbances and impairments in daytime functioning.
The circadian rhythm sleep disorders market was valued at USD 761.23 million in 2023, growing at a CAGR of 6.88% during the forecast period from 2024 to 2030 to reach USD 1,208.86 million by 2030.
The circadian rhythm sleep disorders treatment market is slated to witness prosperity owing to factors such as the rising prevalence of sleep disorders, which is influenced by many factors such as high-stress levels, irregular work schedules, excessive screen, and increasing consumption of alcohol and caffeine. Additionally, the rising geriatric population and increase in sleep awareness campaigns highlighting the advantages of high-quality sleep are some of the key factors that are contributing to the growth of the circadian rhythm sleep disorders treatment market during the forecast period from 2024-2030.
Some of the key market players operating in the Circadian Rhythm Sleep Disorders market Koninklijke Philips N.V., The Sunbox Company, Northern Light Technologies, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., VANDA PHARMACEUTICALS, Nature's Bounty, Verilux, Inc., OLLY Vitamins & Supplements, Pure Encapsulations, LLC, Vespyr Brands, NOW FOODS, Natrol, LLC., Pharmavite LLC, and Others.
North America is expected to dominate the overall Circadian Rhythm Sleep Disorders market during the forecast period, 2024 to 2030. This can be attributed to the rising awareness regarding sleep disorders, increasing R&D activities, growing geriatric population and increasing burden of sleep disorders in the region are some of the contributing factors for the growth of circadian rhythm sleep disorders treatment market in North America.